CARMIL2 Immunodeficiency with Epstein Barr Virus Associated Smooth Muscle Tumor (EBV-SMT). Report of a Case with Comprehensive Review of Literature

Fetal Pediatr Pathol. 2022 Dec;41(6):1023-1034. doi: 10.1080/15513815.2021.2000533. Epub 2021 Nov 5.

Abstract

Background: Primary immunodeficiency (PID) having defects related to lymphocyte cytotoxic pathway or T-cell dysfunction are well known for developing opportunistic infections and Epstein-Barr virus (EBV)-associated diseases. CARMIL2 deficiency is a recently described combined immunodeficiency (CID) disorder characterized by defective CD28-mediated T cell co-stimulation, altered cytoskeletal dynamics, susceptibility to various infections and Epstein Barr Virus smooth muscle tumor (EBV-SMT). Case report: We report a homozygous CARMIL2 pathogenic variant presenting with recurrent infections and EBV associated smooth muscle tumor (SMT) in a child. Conclusion: The present study reports that EBV SMT may occur in a child with CARMIL2 deficiency.

Keywords: CARMIL2 deficiency; EBER; Epstein Barr virus; Primary immunodeficiency; smooth muscle actin; smooth muscle tumor.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Child
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / pathology
  • Herpesvirus 4, Human / genetics
  • Humans
  • Smooth Muscle Tumor* / complications
  • Smooth Muscle Tumor* / genetics
  • Smooth Muscle Tumor* / pathology